Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,003.50
-12.25 (-1.21%)
May 14, 2026, 11:37 AM EDT - Market open
Eli Lilly and Company (LLY) Operating Expense Breakdown
History
| Date | Research and Development | Marketing, Selling, and Administrative | Acquired In-Process Research and Development | Impairment, Restructuring, and Other |
|---|---|---|---|---|
| Mar 31, 2026 | 14.11B | 11.56B | 1.92B | 728.00M |
| Dec 31, 2025 | 13.34B | 11.09B | 2.91B | 484.00M |
| Sep 30, 2025 | 12.56B | 10.39B | 2.57B | 743.90M |
| Jun 30, 2025 | 11.83B | 9.75B | 4.74B | 460.60M |
| Mar 31, 2025 | 11.20B | 9.11B | 4.74B | 895.60M |
| Dec 31, 2024 | 10.99B | 8.59B | 3.28B | 860.60M |
| Sep 30, 2024 | 10.53B | 8.09B | 3.71B | 523.37M |
| Jun 30, 2024 | 10.21B | 7.80B | 3.86B | 441.77M |
| Mar 31, 2024 | 9.85B | 7.61B | 3.81B | 6.77M |
| Dec 31, 2023 | 9.31B | 7.40B | 3.80B | 6.77M |
| Sep 30, 2023 | 8.75B | 7.12B | 3.42B | 38.10M |
| Jun 30, 2023 | 8.14B | 6.93B | 504.60M | 244.60M |
| Mar 31, 2023 | 7.57B | 6.63B | 847.90M | 244.60M |
| Dec 31, 2022 | 7.19B | 6.44B | 908.50M | 244.60M |
| Sep 30, 2022 | 7.15B | 6.39B | 1.11B | 311.00M |
| Jun 30, 2022 | 7.06B | 6.35B | 1.22B | 104.50M |
| Mar 31, 2022 | 6.95B | 6.41B | 823.70M | 104.50M |
| Dec 31, 2021 | 7.03B | 6.43B | 970.10M | 316.10M |
| Sep 30, 2021 | 6.90B | 6.39B | 898.70M | 181.50M |
| Jun 30, 2021 | 6.66B | 6.38B | 721.10M | 282.90M |
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.